BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5
646 results:

  • 1. TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.
    Li MY; Chong LC; Duns G; Lytle A; Woolcock B; Jiang A; Telenius A; Ben-Neriah S; Nawaz W; Slack GW; Elisia I; Viganò E; Aoki T; Healy S; Krystal G; Venturutti L; Scott DW; Steidl C
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2320421121. PubMed ID: 38662551
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epidemiological characteristics and influencing factors of acute leukemia in children and adolescents and adults: a large population-based study.
    Liu S; Hu B; Zhang J
    Hematology; 2024 Dec; 29(1):2327916. PubMed ID: 38578123
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Declining incidence and improving survival of ocular and orbital lymphomas in the US between 1995 and 2018.
    Alfaar AS; Yousef YA; W Wilson M; Hassanain O; Kakkassery V; Moustafa M; Kunbaz A; Esmael A; Strauß O
    Sci Rep; 2024 Apr; 14(1):7886. PubMed ID: 38570585
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Detection of circulating tumor DNA in plasma of patients with primary CNS lymphoma by digital droplet PCR.
    Zhong Y; Tan GW; Bult J; Veltmaat N; Plattel W; Kluiver J; Enting R; Diepstra A; van den Berg A; Nijland M
    BMC Cancer; 2024 Apr; 24(1):407. PubMed ID: 38566053
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.
    Ribelles N; Pascual J; Galvez-Carvajal L; Ruiz-Medina S; Garcia-Corbacho J; Benitez JC; Dominguez-Recio ME; Torres E; Oliva L; Zalabardo M; Rueda A; Alba E
    JCO Glob Oncol; 2024 Mar; 10():e2300363. PubMed ID: 38513186
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019.
    Buja A; De Luca G; Zorzi M; Bovo E; Mocellin S; Trevisiol C; Bronte V; Guzzinati S; Rugge M
    Front Public Health; 2023; 11():1267534. PubMed ID: 38259775
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The burden of acute lymphoid leukemia among adolescents and young adults in the Western Pacific Region: evidence from Global Burden Disease 2019.
    Yang F; Zhang B; Lodder P; Guo J
    Cancer Causes Control; 2024 May; 35(5):839-848. PubMed ID: 38227176
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Variation in patterns of second primary malignancies across U.S. race and ethnicity groups: a Surveillance, Epidemiology, and End Results (SEER) analysis.
    McGuire V; Lichtensztajn DY; Tao L; Yang J; Clarke CA; Wu AH; Wilkens L; Glaser SL; Park SL; Cheng I
    Cancer Causes Control; 2024 May; 35(5):799-815. PubMed ID: 38206498
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Second primary cancers among females with a first primary breast cancer: a population-based study in Northern Portugal.
    Gonçalves E; Fontes F; Rodrigues JR; Calisto R; Bento MJ; Lunet N; Morais S
    Breast Cancer Res Treat; 2024 Apr; 204(2):367-376. PubMed ID: 38151690
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma-affected patients.
    Vanni A; Salvati L; Mazzoni A; Lamacchia G; Capone M; Francalanci S; Kiros ST; Cosmi L; Puccini B; Ciceri M; Sordi B; Rossolini GM; Annunziato F; Maggi L; Liotta F
    Front Immunol; 2023; 14():1322594. PubMed ID: 38106404
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An ultrahigh-performance liquid chromatography-tandem mass spectrometry method for quantification of methotrexate and 7-hydroxy-methotrexate and application for therapeutic drug monitoring in patients with central nervous system lymphoma.
    Huo J; Zhang B; Zhang D; Zhu B; Zhao Z; Mei S
    Biomed Chromatogr; 2024 Feb; 38(2):e5789. PubMed ID: 38037467
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study.
    Ruan X; Huang D; Zhan Y; Huang J; Huang J; Ng AT; Tsu JH; Na R
    Elife; 2023 Nov; 12():. PubMed ID: 37917154
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. MicroRNA as Possible Mediators of the Synergistic Effect of Celecoxib and Glucosamine Sulfate in Human Osteoarthritic Chondrocyte Exposed to IL-1β.
    Cheleschi S; Veronese N; Carta S; Collodel G; Bottaro M; Moretti E; Corsaro R; Barbarino M; Fioravanti A
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834442
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
    Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
    BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.
    Koller P; Baran N; Harutyunyan K; Cavazos A; Mallampati S; Chin RL; Jiang Z; Sun X; Lee HH; Hsu JL; Williams P; Huang X; Curran MA; Hung MC; Konopleva M
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37793852
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.
    Zaninelli S; Meli C; Borleri G; Quaroni M; Pavoni C; Gaipa G; Biondi A; Introna M; Golay J; Rambaldi A; Rambaldi B
    Cytometry A; 2024 Feb; 105(2):112-123. PubMed ID: 37707318
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hand grip strength, short physical performance battery, and gait speed: key tools for function in Non-Hodgkin lymphoma.
    García-Baztán A; Viguria-Alegria MC; Ramón-Espinoza MF; Tamayo-Rodríguez I; Gonzales-Montejo NJ; Martínez-Velilla N; Oteiza-Olaso J
    Ann Hematol; 2023 Oct; 102(10):2823-2834. PubMed ID: 37566279
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019.
    Siegel DA; King JB; Lupo PJ; Durbin EB; Tai E; Mills K; Van Dyne E; Buchanan Lunsford N; Henley SJ; Wilson RJ
    J Natl Cancer Inst; 2023 Nov; 115(11):1337-1354. PubMed ID: 37433078
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Lymphosarcoma Incidence in Kazakhstan: A Retrospective Survey (2010-2019).
    Bayembayev F; Rakhimzhanova R; Dautov T; Saduakassova A; Telmanova Z; Bilyalova Z; Igissinov N
    Asian Pac J Cancer Prev; 2023 Jun; 24(6):1885-1896. PubMed ID: 37378916
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 33.